Copyright
©The Author(s) 2022.
World J Clin Oncol. Jun 24, 2022; 13(6): 496-504
Published online Jun 24, 2022. doi: 10.5306/wjco.v13.i6.496
Published online Jun 24, 2022. doi: 10.5306/wjco.v13.i6.496
Conformer | Affinity energy (kcal/mol) | Dist. From | |
RMSD l.b. | RMSD u.b. | ||
MDM2/protonated DS-3032B | -10.0 | 0.000 | 0.000 |
MDM2/non-protonated DS-3032B | -9.9 | 0.000 | 0.000 |
Residues of MDM2 | Interaction | Bond size (Å) |
Leu 54 | Hydrogen bond | 2.18 |
Leu 57 | Alkyl | 3.92 |
Ile 61 | Alkyl | 3.91 |
Tyr 67 | Pi-Sigma | 3.96 |
Ile 103 | Van der Waals | - |
Phe 86 | Van der Waals | - |
Phe 91 | Van der Waals | - |
Ile 99 | Van der Waals | - |
Tyr 100 | Van der Waals | - |
Val 75 | Van der Waals | - |
Val 93 | Van der Waals | - |
Gln 71 | Van der Waals | - |
Gln 72 | Van der Waals | - |
Gly 58 | Van der Waals | - |
His 73 | Van der Waals | - |
Met 62 | Van der Waals | - |
- Citation: da Mota VHS, Freire de Melo F, de Brito BB, Silva FAFD, Teixeira KN. Molecular docking of DS-3032B, a mouse double minute 2 enzyme antagonist with potential for oncology treatment development. World J Clin Oncol 2022; 13(6): 496-504
- URL: https://www.wjgnet.com/2218-4333/full/v13/i6/496.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i6.496